The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction;O polimorfismo A1166C do receptor tipo 1 da angiotensina II no infarto agudo do miocárdio

Arquivos Brasileiros de Cardiologia

Volumn 83, Issue 5, 2004, Pages 404-413

  De Araújo, Messias Antônio ^a,b,c,d   Soares Menezes, Bruno ^b,c   Lourenço, Clauber ^b,c   Cordeiro, Elisângela Rosa ^b,c   Rispoli Gatti, Renata ^b,c   Goulart, Luiz Ricardo ^b,c  

^a Inst Coracao do Triangulo Mineiro ^*

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c NONE   (Brazil)

^d NONE   (Brazil)

Author keywords

A1166C polymorphism; Acute myocardial infarction; Angiotensin II; Coronary artery disease

Indexed keywords

ADENINE; ANGIOTENSIN 1 RECEPTOR; CYTOSINE; DNA;

3' UNTRANSLATED REGION; A1166C POLYMORPHISM; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; AT1R GENE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE SEVERITY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SCORING SYSTEM; SMOKING; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; MALE; MIDDLE AGED;

CORONARY ARTERIOSCLEROSIS; EPIDEMIOLOGIC METHODS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 9444265918     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2004001700007     Document Type: Article

References (31)

1. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Ver 2000; 52: 415-72.
2. Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-51.
3. Chiu AT, Herblin WF, McCall DE et al. Identification of angiotensin 11 receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203.
4. Paxton WC, Ruglssi, Horulst C, Cohen C, Alexander RW, Bernstein KE. Imunohistochemical localization of rat angiotensin II at 1 receptor. Am J Physiol 1993; 264: 989-95.
5. Krieger EM, Santos RAS. Angiotensinas: Aspectos fisiológicos. Hipertensão 1998; 1: 7-10.
6. Wood AJJ. Angiotensin receptors and their antagonists. Drug Therapy 1996; 334: 1649-54.
7. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.
8. Zhu YZ, Zhu YC, Li J et al. Effects of losartan on hemodynamic parameters and angiotensin receptor m RNA levels of heart alter myocardial infarction. JRAAS 2000; 1: 257-62.
9. Bonnardeaux A, Daves E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994; 24: 63-9.
10. Tiret L, Bonnadeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type receptor gene polymorphism on risk of myocardial infarction. Lancet 1994; 344: 910-4.
11. WHO (report of the joint international society and federation of cardiology/World Health Organization task force on standardization of clinical nomenclature). Nomenclature and criteria for diagnosis of ischaemic heart disease. Circulation 1979; 59: 607-9.
12. Harris PJ, Harrell FE Jr, Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation 1979; 60: 1259-69.
13. Ellis SG, Vandormael MG, Cowley MJ et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990; 82: 1193-202.
14. Califf RM, Phillips HR, Hindman MC et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5: 1055-63.
15. Sambrook J, Fritsch EF, Manitis T. Molecular cloning. 2nd ed. Cold Spring, New York: Cold Spring Harbor Laboratory Press, E.U.A., 1989: 237p.
16. Statistica 5.5 Statsoft, INC (1999). Statistica for Windows.
17. Hosmer DW, Limeshow S. Applied Logistic Regression. New York, John Wiley & Sons, 1989, 307p.
18. Anderson VH, King III SB. Modern approaches to the diagnosis of coronary artery disease. Am Heart Journal 1992; 123: 1312-22.
19. Marmot MG, Syme SL, Kagan A et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975; 102: 514.
20. Sherman CB. Health effects of cigarette smoking. Clin Chest Med, 1991; 4: 643-58.
21. Mc Bride PE. The health consequences of smoking: cardiovascular diseases. Med Clin North Am, 1992; 76: 333-54.
22. Laker MF, Winocour PF. Plasma lipids and lipoproteins in diabetes mellitus. Diabetes Annu 1991; 6: 431-56.
23. Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis 1994; 110(Suppl): 527-33.
24. Hubert HB, Feinleib M, McNamara PT, Castell WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants of the Framingham Heart Study. Circulation 1983; 67: 968-77.
25. Paffenbarger RS, Hade RT, Wing AI et al. The association of changes in physical activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328: 538-45.
26. Milei J & Grana DR. Mortality and morbidity from smoking-induced cardiovascular diseases: the necessity of the cardiologist's involvement and commitment. Int J Cardiol, 1998, 67: 95-109.
27. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997; 52: 77-82.
28. Canavy I, Henry M, Morange PE et al. Genetic polymorphism and coronary artery disease in the south of France. Thromb Haemost 2000; 2: 212-6.
29. Anvari A, Turel Z, Schmidt A et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias. Cardiovasc Res 1999; 43: 879-83.
30. Duncan JA, Scholey JW, Miller JA. Angiotensin II type 1-receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 10: 111-6.
31. Jeunemaitre X, Ledru F, Battaglia S et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997; 99: 66-73.